Insider Transactions in Q1 2021 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
1,987
-63.89%
|
$11,922
$6.0 P/Share
|
|
Mar 12
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
7,367
-100.0%
|
$36,835
$5.99 P/Share
|
|
Mar 02
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
661
-0.48%
|
$3,966
$6.29 P/Share
|
|
Mar 02
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
456
-0.52%
|
$2,736
$6.29 P/Share
|
|
Mar 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
8
-0.26%
|
$48
$6.29 P/Share
|
|
Mar 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
299
-2.01%
|
$1,794
$6.29 P/Share
|
|
Mar 02
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
580
-0.12%
|
$3,480
$6.29 P/Share
|
|
Mar 02
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,032
+1.07%
|
-
|
|
Mar 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,313
+0.94%
|
-
|
|
Mar 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,032
+1.17%
|
-
|
|
Mar 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
19
+0.61%
|
-
|
|
Mar 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
540
+3.49%
|
-
|
|
Mar 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,313
+0.27%
|
-
|
|
Mar 01
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
456
-0.48%
|
$2,736
$6.29 P/Share
|
|
Feb 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
852
-12.94%
|
$6,816
$8.17 P/Share
|
|
Feb 02
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
10,990
-2.2%
|
$76,930
$7.97 P/Share
|
|
Feb 02
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
11,813
-7.86%
|
$82,691
$7.97 P/Share
|
|
Feb 02
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
11,872
-7.76%
|
$83,104
$7.97 P/Share
|
|
Feb 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
5,248
-27.95%
|
$36,736
$7.97 P/Share
|
|
Feb 02
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
11,873
-8.46%
|
$83,111
$7.97 P/Share
|
|
Feb 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,975
+22.73%
|
-
|
|
Feb 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,250
+4.18%
|
-
|
|
Feb 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,250
+12.38%
|
-
|
|
Feb 01
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,125
+12.81%
|
-
|
|
Feb 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,813
+31.08%
|
-
|
|
Feb 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,125
+13.78%
|
-
|